Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a …

WJ Powers, AA Rabinstein, T Ackerson, OM Adeoye… - Stroke, 2019 - Am Heart Assoc
Background and Purpose—The purpose of these guidelines is to provide an up-to-date
comprehensive set of recommendations in a single document for clinicians caring for adult …

European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

C Pristipino, H Sievert, F D'ascenzo… - European Heart …, 2019 - academic.oup.com
The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number
of medical conditions; however, the subject remains controversial and no official statements …

Residual shunt after patent foramen ovale closure and long-term stroke recurrence: a prospective cohort study

W Deng, S Yin, D McMullin… - Annals of internal …, 2020 - acpjournals.org
Background: Residual shunt is observed in up to 25% of patients after patent foramen ovale
(PFO) closure, but its long-term influence on stroke recurrence currently is unknown …

Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network …

H Mir, RAC Siemieniuk, LC Ge, F Foroutan, M Fralick… - BMJ open, 2018 - bmjopen.bmj.com
Objective To examine the relative impact of three management options in patients aged< 60
years with cryptogenic stroke and a patent foramen ovale (PFO): PFO closure plus …

Patent foramen ovale and hypoxemia

MK Mojadidi, JC Ruiz, J Chertoff, MO Zaman… - Cardiology in …, 2019 - journals.lww.com
Patent foramen ovale (PFO), an embryonic remnant of the fetal circulation, is present in 20–
25% of adults. Although recent observational studies and clinical trials have established the …

Management of patients with patent foramen ovale and cryptogenic stroke: an update

M Abdelghani, SAO El-Shedoudy, M Nassif, BJ Bouma… - Cardiology, 2019 - karger.com
Patent foramen ovale (PFO) is a common benign finding in healthy subjects, but its
prevalence is higher in patients with stroke of unclear cause (cryptogenic stroke). PFO is …

Uncertainties and controversies in the management of ischemic stroke and transient ischemic attack patients with patent foramen ovale

SE Kasner, S Lattanzi, AC Fonseca, AY Elgendy - Stroke, 2021 - Am Heart Assoc
Multiple randomized clinical trials have demonstrated the benefit of patent foramen ovale
closure over medical therapy alone for patients who have had a stroke that has been …

Recurrence risk in patients with cryptogenic stroke, patent foramen ovale, and thrombophilia: a systematic review and meta-analysis

CVB Hviid, CZ Simonsen… - Thrombosis and …, 2019 - thieme-connect.com
Objective A patent foramen ovale (PFO) is frequently associated with cryptogenic stroke in
the young. Endovascular closure is superior to antithrombotic treatment in prevention of …

Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention

K Yuan, SE Kasner - Stroke and vascular neurology, 2018 - svn.bmj.com
The patent foramen ovale (PFO), given its high prevalence in the general population and
especially in patients with cryptogenic stroke, has long generated investigation and debate …

Neurological complications of pulmonary embolism: A literature review

PV Desai, N Krepostman, M Collins, S De Sirkar… - Current Neurology and …, 2021 - Springer
Abstract Purpose of Review The present review discusses in-depth about neurological
complications following acute venous thromboembolism (VTE). Recent Findings Intracranial …